Page 26 - 《南京医科大学学报》2026年第1期
P. 26

第46卷第1期
              · 20   ·                           南 京    医 科 大 学 学         报                        2026年1月


                   medullary thyroid carcinoma[J]. Front Oncol,2022,12:  癌颈侧区淋巴结转移的风险模型分析[J]. 中国耳鼻咽
                   883429                                            喉头颈外科,2021,28(11):669-673
             [2] WELLS S A JR,ASA S L,DRALLE H,et al. Revised        YE L Q,MAO X C,DING J W,et al. Risk model analysis
                   American thyroid association guidelines for the manage⁃  of lateral cervical lymph node metastasis in 145 cases of
                   ment of medullary thyroid carcinoma[J]. Thyroid,2015,  operable medullary thyroid carcinoma [ J ]. Chinese
                   25(6):567-610                                     Archives of Otolaryngology ⁃ Head and Neck Surgery,
             [3] FILETTI S,DURANTE C,HARTL D,et al. Thyroid can⁃     2021,28(11):669-673
                   cer:ESMO clinical practice guidelines for diagnosis,treat⁃  [12]SUN H,TIAN W. Chinese guidelines on intraoperative
                   ment and follow⁃up[J]. Ann Oncol,2019,30(12):1856-  neuromonitoring in thyroid and parathyroid surgery(2023
                   1883                                              edition)[J]. Gland Surg,2023,12(8):1031-1049
             [4] 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学                       [13]LIN X,HUO J,SU H,et al. Risk factors for cervical lymph
                   会甲状腺髓样癌诊疗指南2022[M]. 北京:人民卫生出                      node metastasis in the central or lateral cervical region in
                   版社,2022                                           medullary thyroid carcinoma:a systematic review and me⁃
                   Chinese Society of Clinical Oncology Guidelines Working  ta ⁃ analysis[J]. Eur Arch Otorhinolaryngol,2024,281
                   Committee. Chinese Society of Clinical Oncology(CSCO)  (2):547-561
                   diagnosis and treatment guidelines for medullary thyroid  [14]SUBBIAH V,HU M I,MANSFIELD A S,et al. Pralsetinib
                   carcinoma 2022[M]. Beijing:People's Medical Publish⁃  in patients with advanced/metastatic rearranged during
                   ing House,2022                                    transfection(RET)⁃altered thyroid cancer:updated efficacy
             [5] SPANHEIMER P M,GANLY I,CHOU J F,et al. Prophy⁃      and safety data from the ARROW study[J]. Thyroid,
                   lactic lateral neck dissection for medullary thyroid carci⁃  2024,34(1):26-40
                   noma is not associated with improved survival[J]. Ann  [15]谷志远,蔡  赟,陈欢欢,等. SurePath沉降式液基细胞
                   Surg Oncol,2021,28(11):6572-6579                  采集技术应用于甲状腺细针穿刺细胞学诊断的准确性
             [6] 彭    颖,苏艳军,程若川. 外科视角下《CACA甲状腺癌                      评价[J].南京医科大学学报(自然科学版),2024,44
                   诊治指南(2025 版)》更新要点解读[J]. 中华内分泌外                   (11):1550-1557
                   科杂志,2025,19(1):8-13                               GU Z Y,CAI Y,CHEN H H,et al. Accuracy evaluation of
                   PENG Y,SUY J,CHENG R C. Interpretation of key up⁃  SurePath liquid⁃based cytology technique applied in thy⁃
                   dates in the “CACA thyroid carcinoma diagnosis and  roid fine⁃needle aspiration cytological diagnosis[J]. Jour⁃
                   treatment guideline(2025 Edition)”from a surgical per⁃  nal of Nanjing Medical University(Natural Sciences),
                   spective[J]. Chinese Journal of Endocrine Surgery,2025,  2024,44(11):1550-1557
                   19(1):8-13                                   [16]MACHENS A ,LORENZ K ,WEBER F ,et al. Sexual
             [7] COHEN O,BLANK A,MEIERSDORF S,et al. Impact of       dimorphism in medullary thyroid cancer aggressiven ⁃
                   high ⁃ quality ultrasound following community ultrasound  ess[J]. Endocr Relat Cancer,2024,31(3):e230301
                   on surgical planning and active surveillance in patients  [17]COSTA C S,SOUTEIRO P,PAREDES S,et al. Male gen⁃
                   with thyroid cancer[J]. Clin Endocrinol(Oxf),2021,94  der as a poor prognostic factor in medullary thyroid carci⁃
                  (6):990-997                                        noma:behavior or biological difference?[J]. Minerva En⁃
             [8] MENG K,LUO H,CHEN H,et al. Prognostic value of      docrinol(Torino),2023,48(4):395-400
                   numbers of metastatic lymph node in medullary thyroid  [18]LEE S,SHIN J H,HAN B K,et al. Medullary thyroid car⁃
                   carcinoma:a population⁃based study using the SEER 18  cinoma:comparison with papillary thyroid carcinoma and
                   database[J]. Medicine(Baltimore),2019,98(1):e13884  application of current sonographic criteria[J]. AJR Am J
             [9] CHEN D W,LANG B H H,MCLEOD D S A,et al. Thy⁃        Roentgenol,2010,194(4):1090-1094
                   roid cancer[J]. Lancet,2023,401(10387):1531-1544  [19]TRIMBOLI P,MIAN C,PICCARDO A,et al. Diagnostic
             [10]黄思思,郗洪庆,李         晨,等. 甲状腺髓样癌淋巴结转移                  tests for medullary thyroid carcinoma:an umbrella re⁃
                   相关因素及生存分析[J]. 中华内分泌外科杂志,2022,                     view[J]. Endocrine,2023,81(2):183-193
                   16(1):12-17                                  [20]KLAIN M,HADOUX J,NAPPI C,et al. Imaging medul⁃
                   HUANG S S,XI H Q,LI C,et al. Factors associated with  lary thyroid cancer patients with detectable serum mark⁃
                   lymph node metastasis and survival analysis of medullary  ers:state of the art and future perspectives[J]. Endo⁃
                   thyroid carcinoma[J]. Chinese Journal of Endocrine Sur⁃  crine,2022,75(2):330-337
                   gery,2022,16(1):12-17                         (收稿:2025-08-15;修回:2025-10-14;录用:2025-10-15)
             [11]叶柳青,毛晓春,丁金旺,等. 145例可手术甲状腺髓样                                                  (本文编辑:唐       震)
   21   22   23   24   25   26   27   28   29   30   31